Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3984987
Max Phase: Preclinical
Molecular Formula: C47H53ClN6O7S
Molecular Weight: 881.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3984987
Max Phase: Preclinical
Molecular Formula: C47H53ClN6O7S
Molecular Weight: 881.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN1CCC(COc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3ccc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1
Standard InChI: InChI=1S/C47H53ClN6O7S/c1-47(2)18-14-35(41(29-47)33-4-6-36(48)7-5-33)30-52-22-24-53(25-23-52)37-8-11-40(45(27-37)61-38-9-12-42-34(26-38)15-19-49-42)46(55)50-62(58,59)39-10-13-44(43(28-39)54(56)57)60-31-32-16-20-51(3)21-17-32/h4-13,15,19,26-28,32,49H,14,16-18,20-25,29-31H2,1-3H3,(H,50,55)
Standard InChI Key: QTRWQAGIHZWZSY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 881.50 | Molecular Weight (Monoisotopic): 880.3385 | AlogP: 9.15 | #Rotatable Bonds: 13 |
Polar Surface Area: 150.35 | Molecular Species: ZWITTERION | HBA: 10 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.16 | CX Basic pKa: 9.08 | CX LogP: 7.60 | CX LogD: 6.78 |
Aromatic Rings: 5 | Heavy Atoms: 62 | QED Weighted: 0.09 | Np Likeness Score: -0.97 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):